Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan

SUMMARY: This study assessed the cost-effectiveness of continued denosumab treatment, compared with discontinuation of denosumab after one dose, for the treatment of postmenopausal osteoporosis in Taiwan, using real-world fracture reduction effectiveness and cost data. Outcomes indicate that continu...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Ben, Lai, Edward Chia-Cheng, Ou, Huang-tz, Li, Hong, Stollenwerk, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510899/
https://www.ncbi.nlm.nih.gov/pubmed/34636982
http://dx.doi.org/10.1007/s11657-021-01020-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510899/
https://www.ncbi.nlm.nih.gov/pubmed/34636982
http://dx.doi.org/10.1007/s11657-021-01020-6

Ejemplares similares